The arrival of retatrutide, a novel medication for obesity treatment, has naturally sparked significant interest regarding its price. Currently, there is publicly available information regarding the exact retail price of retatrutide. However, industry experts suggest that it will likely be in line with other new generation GLP-1 receptor agonists l